ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Heat Shock Protein 90 Is Involved in Antibody-Mediated Rejection and Is a Potential Target of Anti-Rejection Therapy in Kidney Transplantation

    T. Tanaka, H. Ishida, M. Furusawa, Y. Tamura, H. Kitamura, S. Takahashi, N. Masumori, K. Tanabe, N. Sato, T. Tsukamoto

    Urology, Sapporo Medical University, Sapporo, Japan; Urology, Tokyo Women's Medical University, Tokyo, Japan; Pathology, Sapporo Medical University, Sapporo, Japan

    Purpose: Heat shock protein 90 (HSP90) is a ubiquitously expressed molecular chaperone that is associated with the correct activation of client proteins. Important roles of…
  • 2013 American Transplant Congress

    Treatment of Cryptococcosis in Solid-OrganTransplant Recipients: Relapse Is Rare after Discontinuation of Therapy

    J. Baddley, B. Klausing, K. Brizendine, V. Kumar, B. Julian, D. Eckhoff, J. Tallaj, K. Wille, S. Moser, P. Pappas

    University of Alabama at Birmingham, Birmingham, AL; Birmingham VAMC, Birmingham, AL; Cleveland Clinic, Cleveland, OH

    Background: Cryptococcosis is the third most common fungal infection in solid- organ transplant (SOT) recipients. Current treatment guidelines recommend 6-12 months of antifungal therapy; however,…
  • 2013 American Transplant Congress

    Complement Fixing HLA Antibodies Predict Outcome in HLA Incompatible Renal Transplantation

    C. Clarke, P. Brookes, C. Lawrence, M. Willicombe, P. Dodd, E. Santos-Nunez, J. Galliford, D. Taube

    Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom

    HLA incompatible [HLAi] transplantation is associated with a higher incidence of antibody mediated rejection [AMR] and Transplant Glomerulopathy [TG]. In this study, we show that…
  • 2013 American Transplant Congress

    Probability of Deceased Donor Kidney Transplantation Based on PRA%

    I. Bostock, J. Alberu, A. Adriana, D. Adrian, G. Norma, L. Mayra, C. Natalia, M. Luis, G. Bernardo, V. Mario

    Transplantation Department, Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Distrito Federal, Mexico; Histocompatibility Department, Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Distrito Federal, Mexico

    Sensitization to HLA antigens creates an obstacle for the accessibility and success of kidney transplantation (KT). Highly sensitized patients have longer waiting times and some…
  • 2013 American Transplant Congress

    Class I HLA Mismatches Increase Risk of Acute Rejection, Graft Loss and Formation of De Novo Class II Alloantibody

    E. Casey, M. Gandhi, P. Dean, M. Stegall, F. Cosio

    Nephrology, Transplant Center, Mayo Clinic, Rochester, MN; Surgery, Transplant Center, Mayo Clinic, Rochester, MN; Pathology, Transplant Center, Mayo Clinic, Rochester, MN

    Introduction. With modern immunosuppression it is believed that HLA mismatch (mm) have little impact on kidney graft survival, except for the benefits of 0 HLA…
  • 2013 American Transplant Congress

    Urea-Modified Protein Antigens to Simultaneously Assess CMV-Specific CD4 and CD8 T-Cell Responses Using a New CMV-ELISPOT Assay and Flow-Cytometry

    D. Schub, T. Schmidt, C. Guckelmus, S. Kirsch, L. Deml, U. Sester, M. Sester

    Dpt of Transplant and Infection Immunology, Saarland University, Homburg, Germany; Lophius Biosciences, Regensburg, Germany; Internal Medicine IV, Homburg, Germany

    CMV-specific T-cell monitoring is currently explored as a valuable tool to identify transplant recipients at risk for viral complications. As both CMV-specific CD4 and CD8…
  • 2013 American Transplant Congress

    Prospective, Randomized Pilot Study of B-Cell Targeted Induction Therapy in Sensitized Kidney Transplant Recipients: Final Report, A

    N. Ejaz, A. Shields, R. Alloway, B. Sadaka, A. Girnita, G. Mogilishetty, J. Kremer, M. Cardi, E. Woodle

    U of Cincinnati, Cincinnati; The Christ Hospital, Cincinnati

    Optimal induction therapy for patients at high risk for antibody and/or cell mediated rejection has not been established. This study evaluated addition of B-cell targeting…
  • 2013 American Transplant Congress

    Role of Immunoglobulin (Ig)-G Subclasses and C1q in De Novo HLA DQ DSA Kidney Transplant Outcomes, The

    M. Freitas, L. Rebellato, M. Ozawa, A. Nguyen, M. Everly, N. Sasaki, P. Terasaki

    Terasaki Foundation Laboratory, Los Angeles, CA; One Lambda Inc, Canoga Park, CA; Department of Pathology, Brody School of Medicine at East Carolina University, Greenville, NC

    Background. Anti-HLA DQ antibodies are the predominant HLA class II donor-specific- antibodies (DSAs) after transplantation. Recently, de novo DQ DSA has been associated with worse…
  • 2013 American Transplant Congress

    To Pay or Not To Pay for a Kidney – What Do Patients Think?

    N. Kessaris, M. Lim, A. Vowler, T. Masher, A. Greenberg, P. Thiruchelvam, V. Papalois, E. Kingdon, M. Phanish, N. Mamode, B. Fernando, I. MacPhee, S. Heap

    Guy's Transplant Unit, Guy's Hospital, London, United Kingdom; Renal Unit, St George's Hospital, London, United Kingdom; West London Renal & Transplant Centre, Hammersmith Hospital, London, United Kingdom; Sussex Kidney Unit, Royal Sussex County Hospital, Brighton, United Kingdom; SW Thames Renal & Transplant Unit, St Helier Hospital, Carshalton, United Kingdom; Renal Unit, Royal Free Hospital, London, United Kingdom

    Introduction:The aim of this study was to review patients' thoughts on financial incentives in kidney transplantation in UK.Methods:A questionnaire was sent to patients on the…
  • 2013 American Transplant Congress

    Role of 24 Hour Ambulatory Blood Pressure Monitoring after Pediatric Renal Transplantation

    H. Tran, L. Kjelson, P. Grimm, A. Chaudhuri

    Pediatric Nephrology, Stanford University, Palo Alto, CA

    Introduction: Hypertension (HTN) is an important cardiovascular risk factor influencing patient and allograft survival in renal transplantation. Ambulatory blood pressure monitoring (ABPM) has been found…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences